COHCochlear Limited

COH Stock Price, Valuation & Chart | Cochlear Limited

Compare

$131.13+2.41 (+1.87%)

At close · 16 Oct 2026, 05:10 am

Sector: Healthcare Industry: Medical - Devices Website

Overview Financials Dividends Ratios

COH Historical price chart

COH Key Stats

Market Capitalization8.58B

PE Ratio58.24

EPS2.25

Trading Volume452.68K

Today's High/Low131.49/128.72

Dividend Yield3.85

52 Week High/Low296.5/88.74

Shares Outstanding65.40M

COH Financial Statement

COH Analyst ratings

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Based on 15 analysts giving stock ratings to COH in the past 3 months.

COH Analysis & performance metrics

COH Company profile

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction…

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.

COH Management team

Name

Position

Greg Bodkin BE (Hons), MComm (UNSW)

Senior Vice President of Global Supply Chain

Kimberley Simpson

Head of Group Tax

Rob McGrory

Group General Counsel & Company Secretary

Diggory William Howitt BE (Hons), MBACEO

Chief Executive Officer, MD, President & Executive Director

Jennifer Stevenson

Vice President of Corporate Communications & Brand

Jan Janssen MSc Elec EngCTO

Chief Technology Officer

Karen O'DriscollCTO

Chief Information Officer

Kristina Devon

Vice President of Investor Relations

Name

Position

Greg Bodkin BE (Hons), MComm (UNSW)

Senior Vice President of Global Supply Chain

Kimberley Simpson

Head of Group Tax

Rob McGrory

Group General Counsel & Company Secretary

Diggory William Howitt BE (Hons), MBACEO

Chief Executive Officer, MD, President & Executive Director

Jennifer Stevenson

Vice President of Corporate Communications & Brand

Jan Janssen MSc Elec EngCTO

Chief Technology Officer

Karen O'DriscollCTO

Chief Information Officer

Kristina Devon

Vice President of Investor Relations

Management Team

Greg Bodkin BE (Hons), MComm (UNSW)

Senior Vice President of Global Supply Chain

Kimberley Simpson

Head of Group Tax

Rob McGrory

Group General Counsel & Company Secretary

Diggory William Howitt BE (Hons), MBACEO

Chief Executive Officer, MD, President & Executive Director

Jennifer Stevenson

Vice President of Corporate Communications & Brand

Jan Janssen MSc Elec EngCTO

Chief Technology Officer

Karen O'DriscollCTO

Chief Information Officer

Kristina Devon

Vice President of Investor Relations

Management

Greg Bodkin BE (Hons), MComm (UNSW)

Senior Vice President of Global Supply Chain

Kimberley Simpson

Head of Group Tax

Rob McGrory

Group General Counsel & Company Secretary

Diggory William Howitt BE (Hons), MBACEO

Chief Executive Officer, MD, President & Executive Director

Jennifer Stevenson

Vice President of Corporate Communications & Brand

Jan Janssen MSc Elec EngCTO

Chief Technology Officer

Karen O'DriscollCTO

Chief Information Officer

Kristina Devon

Vice President of Investor Relations

Total 8 executives

COH Frequently asked questions

What is Cochlear Limited (COH) Stock Price?

Current stock price of Cochlear Limited (COH) stock is $131.13. The stock price is +1.87% higher in the session. The intraday range can be seen from this page. Volume of Cochlear Limited (COH) stock is 452.68K.

Last updated at 16 Oct 2026, 05:10 am.

Why is the Cochlear Limited (COH) stock price going up or down today?

The stock price of Cochlear Limited (COH) can change with earnings, company news, and overall market sentiment. Cochlear Limited operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cochlear Limited stock expensive at its current price?

Whether Cochlear Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for COH on this page is 58.24. EPS on this page is 2.25. Compare those figures with peers and growth expectations before deciding if the current Cochlear Limited price is justified.

How has the stock price of Cochlear Limited (COH) performed historically?

Historical performance for Cochlear Limited (COH) is shown on the price chart on this page. Review multi-period moves alongside volume to see how COH reacted to past earnings and market events.

Should I buy Cochlear Limited (COH) stock, at this price?

Buying Cochlear Limited (COH) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.